Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

Abstract

This study provides another line of evidence that Hedgehog signalling is a valid target for the development of novel therapeutics for pancreatic cancer that might be worth evaluating soon in a clinical setting.